Genomic Vision (FRA:G09) Additional Paid-In Capital : €27.82 Mil(As of Jun. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Genomic Vision Additional Paid-In Capital?

Genomic Vision's quarterly additional paid-in capital increased from Jun. 2022 (€25.27 Mil) to Dec. 2022 (€27.16 Mil) and increased from Dec. 2022 (€27.16 Mil) to Jun. 2023 (€27.82 Mil).

Genomic Vision's annual additional paid-in capital increased from Dec. 2020 (€23.15 Mil) to Dec. 2021 (€25.02 Mil) and increased from Dec. 2021 (€25.02 Mil) to Dec. 2022 (€27.16 Mil).

Genomic Vision Additional Paid-In Capital Historical Data

The historical data trend for Genomic Vision's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomic Vision Additional Paid-In Capital Chart

Genomic Vision Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

18.09

19.41

23.15

25.02

27.16

Genomic Vision Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Additional Paid-In Capital	Get a 7-Day Free Trial															23.97	25.02	25.27	27.16	27.82

Genomic Vision Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Genomic Vision Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Genomic Vision's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomic Vision (FRA:G09) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomic Vision SA (FRA:G09) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

80-84 rue des Meuniers, Green Square, Batiment E, Bagneux, FRA, 92220

Website

http://www.genomicvision.com

Genomic Vision SA is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics.

Genomic Vision (FRA:G09) Headlines

No Headlines